Effects of tacrolimus treatment on the gut microbiota and metabolites in liver transplant recipients
PLOS One · 2026
DOI: 10.1371/journal.pone.0343817 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Guohui Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First People's Hospital of Kunming City and Calmette Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, …. Hauptthemen laut MEDLINE: Tacrolimus, Liver Transplantation, Gastrointestinal Microbiome, Immunosuppressive Agents. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Basic Research Program of Yunnan Science and Technology Department, Yunnan Provincial Health Commission Medical Leading Talent Training Program, Construction Unit of Yunnan Provincial Clinical Pharmacy Center.
Abstract (Originalsprache)
Background
Liver transplantation (LT) is an effective treatment for patients with end-stage liver disease. In recent years, more and more evidence has supported the association between gut microbiota dysbiosis and the pathogenesis and progression of liver diseases.
Methods
The study included 36 patients who received tacrolimus treatment after liver transplantation. Patients were stratified into subgroups according to three key variables: tacrolimus treatment duration, whole-blood tacrolimus concentration, and tacrolimus concentration-to-dose (C/D) ratio. Fecal samples and whole-blood specimens were collected from all participants. The Illumina HiSeq X platform was used to detect the gut metagenome, analyzing the composition and characteristics of the gut microbiota. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) technology was employed to detect metabolites of the gut microbiota, revealing their metabolic profiles.
Results
As the duration of tacrolimus use increased, the diversity of the gut microbiota also increased, and the abundance of Escherichia coli_D and Bacteroides stercoris rose. Additionally, the abundance of Brunovirus and Uetakevirus tended to decrease. The abundance of gene functions related to chemical carcinogenesis and bacterial invasion of epithelial cells significantly decreased. In the gut microbiota metabolites, 16 substances like Astragaloside A and Acetyl-L-carnitine significantly increased, while 108 substances like Capsaicin and TLK significantly decreased. Within a certain range, as the concentration of tacrolimus in whole blood increased, the diversity of the gut microbiota increased. The abundance of Phocaeicola and Klebsiella increased, and the abundance of Peduovirus among viruses also rose. However, excessively high concentrations may lead to a decrease in the diversity of the gut microbiota and a decrease in the abundance of Phocaeicola . With respect to the C/D ratio, increased ratios were linked to significantly higher levels of 57 fecal metabolites (e.g., PC 34:2, 5-Methyl-2’-deoxycytidine), whereas 13 metabolites (e.g., FAHFA 2:0/16:0) showed substantial declines.
Conclusions
Tacrolimus treatment is associated with distinct alterations in gut microbiota and metabolites among LT recipients. These findings provide a preliminary framework for future investigations aimed at optimizing immunosuppressive regimens, although their clinical translational potential requires validation in larger-scale, prospective cohort studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First People's Hospital of Kunming City and Calmette Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
ORCID-Profile: Guohui Wang
Förderung
- the Basic Research Program of Yunnan Science and Technology Department
- Yunnan Provincial Health Commission Medical Leading Talent Training Program
- Construction Unit of Yunnan Provincial Clinical Pharmacy Center
- Kunming City Health Science and Technology Talents Training Program
Zitieren
APA
Wang, G., Liu, L., Zhang, H., Mao, P., Lu, S., Zhang, X., Li, X., & Song, C. (2026). Effects of tacrolimus treatment on the gut microbiota and metabolites in liver transplant recipients. PLOS One. https://doi.org/10.1371/journal.pone.0343817
Vancouver
Wang G, Liu L, Zhang H, Mao P, Lu S, Zhang X, et al. Effects of tacrolimus treatment on the gut microbiota and metabolites in liver transplant recipients. PLOS One. 2026. doi:10.1371/journal.pone.0343817
BibTeX
@article{Wang2026,
author = {Wang, Guohui and Liu, Lu and Zhang, Hanshu and Mao, Panpan and Lu, Saijuan and Zhang, Xiaofang and Li, Xingde and Song, Cangsang},
title = {Effects of tacrolimus treatment on the gut microbiota and metabolites in liver transplant recipients},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0343817}
}
EUVIMED